Omixon and Algimed Sign Partnership Agreement

14/01/2019

At Omixon we are working hard to expand our customer base and it is always a pleasure and excitement to share the news of new collaborations, partnerships and distribution agreements. This time we are happy to announce that with the help of the Minsk-based Algimed, Omixon is now represented...

Omixon and World Fusion Extend Their Partnership in Japan

27/10/2017

World Fusion is a leading bioinformatics company in Japan that focuses on therapeutic target discovery, gene expression analysis, and variant analysis. Their highly skilled and motivated team has been the successful marketer of Omixon’s software products since 2014, and we are pleased to announce World Fusion as a distributor...

Omixon and Promovendo Form Partnership in Brazil

19/10/2017

Omixon is pleased to announce an Exclusive Distribution and Support Partnership with Promovendo, headquarted in Brazil. “Promovendo’s dedication, rich experience and extended network within the HLA-typing field will make them an excellent asset to the Omixon team. We believe the transplantation community will stand to benefit from Omixon’s world...

Omixon and TBG form Partnership for Asia-Pacific

16/11/2016

Omixon and TBG Biotechnology Corp. (TBG), headquartered in Taiwan announce an Exclusive Distribution and Support Partnership for the Asia-Pacific region, including China, Hong Kong, Taiwan and Australia. TBG will be the exclusive distributor of Omixon’s world leading Holotype HLA product for HLA typing by NGS. “With a common goal of driving adoption of...

New Distributor in South Korea

08/08/2016

Omixon announce today a new partnership with Commugene in South Korea. Through our cooperation, from one of the fastest growing markets in the world, researchers in the biotechnology industry will have easier access to Omixon’s high-performance, high-throughput and high-resolution multi-sample kit and software only products for HLA genotyping analysis by Next Generation Sequencing for use on the...